General MedicationsORALStandard
ERYTHROMYCIN
ERYTHROMYCIN
Standard Dose
333MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 211975 (ANDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient ERYTHROMYCIN Form and strength TABLET, DELAYED RELEASE;ORAL - 333MG Sponsor TORRENT Submission history Latest submission status date: 2024-08-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 211975 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient ERYTHROMYCIN Form and strength TABLET, DELAYED RELEASE;ORAL - 333MG Sponsor TORRENT Submission history Latest submission status date: 2024-08-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.